Mirjam Weibel
- Molecular Biology
- Clinical Biochemistry top 1%
- Immunology
- Physiology
- Pulmonary and Respiratory Medicine
- Co-authors
- Claus W. HeizmannArnaud GalichetEstelle LeclercG. FritzEmmanuel SturchlerHansruedi BüelerMatthias HöchliStefano Ferrari
- Topics
- Advanced Glycation End Products research (4 papers)S100 Proteins and Annexins (4 papers)Alzheimer's disease research and treatments (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Mirjam Weibel
10 papers receiving 778 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 514
- Clinical Biochemistry 296
- Immunology 144
- Physiology 131
- Pulmonary and Respiratory Medicine 86
Countries citing papers authored by Mirjam Weibel
This map shows the geographic impact of Mirjam Weibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Weibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Weibel more than expected).
Fields of papers citing papers by Mirjam Weibel
This network shows the impact of papers produced by Mirjam Weibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Weibel. The network helps show where Mirjam Weibel may publish in the future.
Co-authorship network of co-authors of Mirjam Weibel
This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam Weibel. A scholar is included among the top collaborators of Mirjam Weibel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam Weibel. Mirjam Weibel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 89 | |
| 2 | 113 | |
| 3 | 228 | |
| 4 | 62 | |
| 5 | 35 | |
| 6 | 125 | |
| 7 | 79 | |
| 8 | 21 | |
| 9 | 36 | |
| 10 | 3 |
About Mirjam Weibel
Mirjam Weibel is a scholar working on Clinical Biochemistry, Environmental Chemistry and Neurology, having authored 10 papers that have together received 791 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), S100 Proteins and Annexins (4 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Clinical Biochemistry (296 citations), Molecular Biology (514 citations) and Immunology (144 citations). Mirjam Weibel has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Claus W. Heizmann, Arnaud Galichet, Estelle Leclerc, G. Fritz, Emmanuel Sturchler, Hansruedi Büeler, Matthias Höchli, Stefano Ferrari, Beat W. Schäfer and Miro Makek. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.